Company Filing History:
3 out of 3 
1 out of 1 
1 out of 35 
Years Active: 2019-2024
Title: The Innovations of Dana Larocca: A Pioneer in Stem Cell Research
Introduction: Dana Larocca, an accomplished inventor based in Alameda, California, has made significant contributions to the field of biotechnology. With a remarkable portfolio of five patents, Larocca focuses on groundbreaking research aimed at combating age-related diseases and enhancing our understanding of cellular reprogramming.
Latest Patents: Among Dana's latest patents is the development of supercentenarian induced pluripotent stem (sciPS) cells. This innovative work provides methods for reprogramming iPS cells from supercentenarians, presenting differentiated derivatives that possess unique characteristics contributing to disease resistance and longevity. Furthermore, this patent outlines techniques for treating and preventing age-related ailments through the administration of therapeutic sciPS-derived cells. Another noteworthy invention involves exosomes isolated from clonal progenitor cells, which includes methods, compositions, and kits for their applications in various biomedical fields.
Career Highlights: Throughout his career, Dana Larocca has worked with notable companies in the biotechnology sector, including Recyte Therapeutics, Inc. and Mandala Biosciences, LLC. His expertise in stem cell research and cell-derived reagents positions him as a leader in his field, continuously pushing the boundaries of scientific innovation.
Collaborations: Dana has collaborated with esteemed colleagues, including Paola A Bignone and Mohammad Hassanipour. These partnerships have fueled advancements in stem cell technology and have facilitated the creation of novel therapeutic approaches to combat age-related diseases.
Conclusion: Dana Larocca's contributions to stem cell innovation illustrate the potential for developing therapies that enhance human longevity and treat age-related diseases. Through his patents and collaborative efforts, Larocca represents a pivotal figure in ongoing research endeavors, undoubtedly shaping the future of biotechnology and medical science.